Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2010
Operating activities      
Net earnings $ 87,290 $ 111,559 $ 24,031
Non-cash items:      
Depreciation and amortization 54,263 52,996 51,875
Net loss (gain) on disposal of business   11,695 (334)
Stock-based compensation expense 13,346 10,758 8,399
Provision (benefit) for deferred income taxes (10,524) 6,480 (2,876)
Amortization of debt discount and debt issuance costs 1,990 2,904 3,969
Impairment charges 62,464    
Impairment charges     36,139
Non-cash debt refinancing costs 2,254    
Other non-cash adjustments   (46) (855)
Changes in components of working capital and other:      
Accounts receivable (12,310) (2,564) (14,507)
Expiration of accounts receivable securitization program     (37,106)
Inventories 11,532 (29,909) (7,964)
Prepaid expenses and other assets (2,164) 5,876 3,817
Trade accounts payable 5,902 7,158 32,727
Income taxes payable (17,903) 4,155 16,000
Accrued compensation and benefits (6,292) 12,178 27,361
Other accrued liabilities (7,519) (21,674) (19,590)
Cash provided by operating activities 182,329 171,566 121,086
Investing activities      
Proceeds from sale of property, plant and equipment 8,501 1,779 1,236
Proceeds from sale of businesses   3,463 7,516
Capital expenditures (22,740) (23,096) (19,966)
Business acquisitions, net of cash acquired (70,267) (313,456) (45,866)
Cash used in investing activities (84,506) (331,310) (57,080)
Financing activities      
Net borrowings (repayments) on revolver (58,167) 58,204 (14,313)
Principal repayments on term loans (2,500)    
Proceeds from issuance of term loans   100,000  
Repurchases of 2% Convertible Notes (102) (34) (22,894)
Proceeds from issuance of 5.625% Senior Notes 300,000    
Redemption of 6.875% Senior Notes (250,000)    
Debt issuance costs (5,490) (5,197)  
Purchase of treasury shares (63,083)    
Stock option exercises, related tax benefits and other 10,913 8,235 3,315
Cash dividend (2,748) (2,716) (2,702)
Cash provided by (used in) financing activities (71,177) 158,492 (36,594)
Effect of exchange rate changes on cash (2,683) 5,251 1,425
Net increase in cash and cash equivalents 23,963 3,999 28,837
Cash and cash equivalents-beginning of period 44,221 40,222 11,385
Cash and cash equivalents-end of period $ 68,184 $ 44,221 $ 40,222